DK88989D0 - Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse - Google Patents

Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse

Info

Publication number
DK88989D0
DK88989D0 DK088989A DK88989A DK88989D0 DK 88989 D0 DK88989 D0 DK 88989D0 DK 088989 A DK088989 A DK 088989A DK 88989 A DK88989 A DK 88989A DK 88989 D0 DK88989 D0 DK 88989D0
Authority
DK
Denmark
Prior art keywords
intermediates
procedures
preparation
substituted pyrimidines
pyrimidines
Prior art date
Application number
DK088989A
Other languages
English (en)
Inventor
Peter Fey
Rolf Angerbauer
Walter Huebsch
Hilmar Bischoff
Dieter Petzinna
Delf Schmidt
Guenter Thomas
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25865194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK88989(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE3805913A external-priority patent/DE3805913A1/de
Priority claimed from IT8822721A external-priority patent/IT1227543B/it
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK88989D0 publication Critical patent/DK88989D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK088989A 1988-02-25 1989-02-24 Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse DK88989D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3805913A DE3805913A1 (de) 1988-02-25 1988-02-25 Substituierte pyrimidine
IT8822721A IT1227543B (it) 1988-11-24 1988-11-24 Pirimidine sostituite.

Publications (1)

Publication Number Publication Date
DK88989D0 true DK88989D0 (da) 1989-02-24

Family

ID=25865194

Family Applications (1)

Application Number Title Priority Date Filing Date
DK088989A DK88989D0 (da) 1988-02-25 1989-02-24 Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse

Country Status (9)

Country Link
EP (1) EP0330057A2 (da)
JP (1) JPH01261377A (da)
CN (1) CN1036954A (da)
AU (1) AU3020289A (da)
DK (1) DK88989D0 (da)
FI (1) FI890868A (da)
IL (1) IL89376A0 (da)
NO (1) NO890521L (da)
PT (1) PT89809A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87929B (pt) * 1987-07-10 1995-03-01 Hoechst Ag Processo para a preparacao de derivados de acido 3-desmetil-mevalonico e de composicoes farmaceuticas que os contem
DE3826814A1 (de) * 1988-08-06 1990-02-08 Hoechst Ag Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
DE3832570A1 (de) * 1988-09-24 1990-03-29 Hoechst Ag 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
DE69527684T2 (de) 1994-09-06 2002-11-28 Ube Industries, Ltd. Herstellung von 3-oxy-5-oxo-6-Heptensäurederivaten
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
TW200614993A (en) * 2004-06-11 2006-05-16 Akzo Nobel Nv 4-phenyl-pyrimidine-2-carbonitrile derivatives
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
EP2626069A4 (en) 2010-10-06 2014-03-19 Univ Tokyo A MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF A DERY LYMPH
EP3184103A1 (en) 2015-12-21 2017-06-28 Hexal AG Pharmaceutical composition comprising atorvastatin or a salt thereof

Also Published As

Publication number Publication date
IL89376A0 (en) 1989-09-10
FI890868A0 (fi) 1989-02-23
NO890521L (no) 1989-08-28
PT89809A (pt) 1989-10-04
EP0330057A2 (de) 1989-08-30
FI890868A (fi) 1989-08-26
NO890521D0 (no) 1989-02-08
AU3020289A (en) 1989-08-31
JPH01261377A (ja) 1989-10-18
CN1036954A (zh) 1989-11-08

Similar Documents

Publication Publication Date Title
DK345488D0 (da) Azolylmethyl-cyclopropyl-derivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK120188A (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK316189A (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK300688A (da) Heterocycliske hydroxyethylazolderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK622888A (da) 3-cyano-4-phenyl-pyrrolderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
NO875051D0 (no) Derivater og bicykliske aminokarboksylsyrer, fremgangsmaate og mellomprodukter til deres fremstilling, samt deres anvendelse.
DK88989D0 (da) Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK494589D0 (da) Substituerede 1,3,5-triazintrioner og deres anvendelse samt mellemprodukter til deres fremstilling
DK104589A (da) Substituerede acrylsyreestere, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK436388D0 (da) Substituerede pyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK358389A (da) 4-halogen-5-nitrothiazol-derivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK639888D0 (da) 3-aminopyrazolin-5-oner, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK622988A (da) 3-cyano-4-phenyl-pyrrolderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK79389A (da) Thiorhodaminer samt fremgangsmaade og mellemprodukter til deres fremstilling
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK247884A (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider, fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen
DK355389A (da) Hydroxyalkynyl-azolylderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK259089A (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK144989D0 (da) Disubstituerede pyrroler, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK355289A (da) 2,2-dihalogencyclopropyl-hydroxy-ethyltriazoler, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK631288D0 (da) Substituerede pyrimidinderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK703688D0 (da) Substituerede pyrimidiner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK264788A (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK436588A (da) Substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse